Sexual Dysfunctions, Gender Dysphoria, and Paraphilic Disorders

  • Raman Marwaha
  • Poorvanshi Alag
  • Amit Thour


Sexual disorders are highly prevalent in the elderly, yet little is known about them. They include sexual dysfunctions, paraphilic disorders, and gender dysphoria. Sexual dysfunctions are characterized by diminished or absent sexual interests and imbalance in physiological and psychological patterns. Paraphilias represent deviant or perverse sexual behavior, while gender dysphoria is the condition of a person feeling that their gender identity is opposite to their biological sex. These problems can get aggravated by the process of aging or by the presence of multiple stressors and chronic conditions. Physicians should give these patients the opportunity to voice their concerns regarding sexual functions and offer alternatives for evaluations and treatment. In this chapter we review the epidemiology, neurobiology, diagnosis, and treatments for these important disorders.


Sexual dysfunctions Gender dysphoria Paraphilic disorders Sexual response cycle Sex therapy 


  1. 1.
    Glasier A, Gülmezoglu A, Schmid GP, et al. Sexual and reproductive health: a matter of life and death. Lancet. 2006;368(9547):1595–607.CrossRefPubMedGoogle Scholar
  2. 2.
    Archer J, Lloyd B. Sex and gender. Cambridge. Retrieved 2002: Cambridge University Press; 2012. p. 85–8.Google Scholar
  3. 3.
    Balon R. The DSM criteria of sexual dysfunction: need for a change. J Sex Martial Ther. 2008;34(3):186–97.CrossRefGoogle Scholar
  4. 4.
    Hoeksema SN. Abnormal psychology. New York, NY: McGraw-Hill; 2014. p. 366–7.Google Scholar
  5. 5.
    Lindua ST, Schumm LP, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357(8):762–74.CrossRefGoogle Scholar
  6. 6.
    Schick V, Herbenick D, Reece M, et al. Sexual behaviors, condom use and sexual health of Americans over 50; implications for sexual health promotion for older adults. J Sex Med. 2010;7(5):315–29.CrossRefPubMedGoogle Scholar
  7. 7.
    Lewis RW, Fugl-Meyer KS, Bosch R, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med. 2004;1:35–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Laumann EO, Waite LJ. Sexual dysfunction among older adults: prevalence and risk factors from a nationally representative U.S. probability sample of men and women 57-85 years of age. J Sex Med. 2008;5(10):2300–11.CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts male ageing study. J Urol. 1994;151:54–61.CrossRefPubMedGoogle Scholar
  10. 10.
    Abdallah RT, Simon JA. Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder.Google Scholar
  11. 11.
    Ludwig W, Phillips M. Organic causes of erectile dysfunction in men under 40. Urol Int. 2003;92(3):553–62.Google Scholar
  12. 12.
    Thomas DR. Medications and sexual function. Clin Geriatr Med. 2003;19(3):535–62.CrossRefGoogle Scholar
  13. 13.
    Liu L, Zhao S, Zhang T, et al. Sexual dysfunction in patients with obstructive sleep apnea: a systematic review and meta-analysis. J Sex Med. 2015;12:1992–2003.CrossRefPubMedGoogle Scholar
  14. 14.
    Nicolai MPJ, Liem SS, Both S, et al. A review of positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice. Neth Heart J. 2014;22(1):11–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Segraves RT, Balon R. Antidepressant induced sexual dysfunction in men. Pharmacol Biochem Behav. 2014;121:132–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Zajecka J. Stratergies for the treatment of antidepressant related sexual dysfunction via avoidance, switching antidepressants, antidotes and adaptation. J Clin Psychiatry. 2003;64(Suppl 10):11–9.Google Scholar
  17. 17.
    McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int. 2006;97(Suppl 2):23–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Hansen BL. Lower urinary tract symptoms (LUTS) and sexual function in both sexes. Eur Urol. 2004;46:229–34.CrossRefPubMedGoogle Scholar
  19. 19.
    Currey HLF. Osteoarthritis of hip joint and sexual activity. Ann Rheum Dis. 1970;29:488–93.CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Nikoobakht M, Nasseh H, Pourkasmaee M. The relationship between lipid profile and erectile dysfunction. Int J Impot Res. 2005;17:523–36.CrossRefPubMedGoogle Scholar
  21. 21.
    Billups KL, et al. Erectile dysfunction is a marker of cardiovascular disease: results of the minority health institute expert advisory panel. J Sex Med. 2005;2:40–52.CrossRefPubMedGoogle Scholar
  22. 22.
    Morley JE, Tariq SH. Sexuality & disease. Clin Geriatr Med. 2003;19:563–73.CrossRefPubMedGoogle Scholar
  23. 23.
    Agronin ME. Sexuality and ageing. In: Binik YM, Hall KSK, editors. Principles and practice of sex therapy. 5th ed. New York: Guilford; 2014. p. 529–39.Google Scholar
  24. 24.
    Dunn KM, Croft PR, Hackett GI. Association of sexual problems with social, psychological, and physical problems in men and women: a cross sectional population survey. J Epidemiol Community Health. 1999;53:144–8.CrossRefPubMedCentralPubMedGoogle Scholar
  25. 25.
    Bitzer J, Platano G, Tschudin S, et al. Sexaul counseling in elderly couples. J Sex Med. 2008;5(9):2027–43.CrossRefPubMedGoogle Scholar
  26. 26.
    Segraves RT, Lee J, Stevenson R. Tadalafil for treatment of erectile dysfunction in men on antidepressant. J Clin Psychopharmacol. 2007;27(1):62–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Clayton AH, Croft HA, Handiwala L. Antidepressants and sexual dysfunction: mechanisms & clinical implications. Postgrad Med. 2014;126(2):91–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Reichenpfader U, Gartlehner G, Morgon LC, et al. Sexual dysfunction associated with second generation antidepressants in patients with major depressive disorder: results from systematic review with network metaanalysis. Drug Saf. 2014;37(1):19–31.CrossRefPubMedGoogle Scholar
  29. 29.
    Baggaley M. Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol. 2008;23(3):201–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Serretti A, Chiesa A. A meta analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol. 2011;26(3):30–140.CrossRefGoogle Scholar
  31. 31.
    Taylor MJ, Rudkin L, Bullemor-Day P, et al. Strategies for managing sexual dysfunction induced by antidepressant medications. Cochrane Database Syst Rev. 2013;5:CD003382.Google Scholar
  32. 32.
    Boolell M, Gepi AS, Gingell JC, et al. Sildenafil a novel effective oral therapy for male erectile dysfunction. Br J Urol. 1996;78(2):257–61.CrossRefPubMedGoogle Scholar
  33. 33.
    Porst H, Young JM, Schmidt AC, et al. Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in pt subgroups. Urology. 2003;62(3):519–23.CrossRefPubMedGoogle Scholar
  34. 34.
    Porst H, Montorsi F, Rosen RC, et al. The premature ejaculations prevalence and attitudes survey: prevalence comorbidites and professional help seeking. Eur Urol. 2006;51(3):816–23.CrossRefPubMedGoogle Scholar
  35. 35.
    Berigan T. Antidepressant induced sexual dysfunction treated with vardenafil. Can J Psychiatr. 2004;49(9):643.CrossRefGoogle Scholar
  36. 36.
    Brotto L, Luria M. Sexual interest/arousal disorder in women, principles and practice of sex therapy. 5th ed. New York: Guilford; 2014. p. 17–41.Google Scholar
  37. 37.
    Cohen-Kettenis PT, Gooren LJ. Transsexualism: a review of etiology, diagnosis and treatment. J Psychosom Res. 1999;46(4):315–33.CrossRefPubMedGoogle Scholar
  38. 38.
    Chivers ML, Bailey JM. Sexual orientation of female-to-male transsexuals: a comparison of homosexual and nonhomosexual types. Arch Sex Behav. 2000;29(3):259–78.CrossRefPubMedGoogle Scholar
  39. 39.
    Collier CM, O'Boyle M, Emory LE, et al. Co-morbidity of gender dysphoria and other major psychiatric diagnoses. Arch Sex Behav. 1997;26(1):13–26.CrossRefGoogle Scholar
  40. 40.
    Hoshiai M, Matsumoto Y, Sato T, et al. Psychiatric co-morbidity among patients with gender identity disorder. Psychiatry Clin Neurosci. 2010;64(5):514–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Madeddu F, Prunas A, Hartmann D, et al. Prevalence of Axis II disorders in a sample of clients undertaking psychiatric evaluation for sex reassignment surgery. Psychiatr Q. 2009;80(4):261–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Zucker KJ, Wood H, Singh D, et al. A developmental, biopsychosocial model for the treatment of children with gender identity disorder. J Homosex. 2012;59(3):369–97.CrossRefPubMedGoogle Scholar
  43. 43.
    Coolidge FL, Thede LL, Young SE. The heritability of gender identity disorder in a child and adolescent twin sample. Behav Genet. 2002;32(4):251–7.CrossRefPubMedGoogle Scholar
  44. 44.
    Bao AM, Swaab DF. Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuropsychiatric disorders. Front Neuroendocrinol. 2011;32(2):214–26.CrossRefPubMedGoogle Scholar
  45. 45.
    Aydin D, Buk LJ, Partoft S, et al. Transgender surgery in Denmark from 1994 to 2015: 20-year follow-up study. J Sex Med. 2016;13(4):720–5.CrossRefPubMedGoogle Scholar
  46. 46.
    Selvaggi G, Dhejne C, Landen M, et al. The 2011 WPATH standards of care and penile reconstruction in female-to-male transsexual individuals. Adv Urol. 2012;2012:581712.CrossRefPubMedCentralPubMedGoogle Scholar
  47. 47.
    Murad MH, Elamin MB, Garcia MZ, et al. Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin Endocrinol. 2010;72(2):214–31.CrossRefGoogle Scholar
  48. 48.
    Balon R. Politics of diagnostic criteria: specifies of pedophilic disorders in DSM-5. Arch Sex Behav. 2014;43:1235–6.CrossRefPubMedGoogle Scholar
  49. 49.
    American Psychiatric Association. "Paraphilic Disorders". Diagnostic and statistical manual of mental disorders. 5th ed. Virginia: American Psychiatric Publishing; 2013. p. 685–6.CrossRefGoogle Scholar
  50. 50.
    Konrad N, Welke J, Opitz- Welke A. Paraphilias. Curr Opin Psychiatry. 2015;28(6):440–4.CrossRefPubMedGoogle Scholar
  51. 51.
    Campbell MM, Artz L, Stein DJ. Sexual disorders in DSM-5 and ICD-11: a conceptual framework. Curr Opin Psychiatry. 2015;28(6):435–9.CrossRefPubMedGoogle Scholar
  52. 52.
    Bhugra D, Popelyuk D, McMullen I. Paraphilias across cultures: contexts and controversies. J Sex Res. 2010;4:242–56.CrossRefGoogle Scholar
  53. 53.
    Ahlers CJ, Schaefer GA, Mundt IA. How unusual are the contents of paraphilia- associated sexual arousal patterns in a community based sample of men. J Sex Med. 2011;8:1362–70.CrossRefPubMedGoogle Scholar
  54. 54.
    Leo RJ, Kim RY. Clomipramine treatment of paraphilias on elderly demented patients. J Geriatr Psychiatry Neurol. 1995;8:123–4.CrossRefPubMedGoogle Scholar
  55. 55.
    Philpot CD. Paraphilia and aging. Clin Geriatr Med. 2003;19(3):629–36.CrossRefPubMedGoogle Scholar
  56. 56.
    Sollo P, Bortolato M, Cannas A, et al. Paraphilias and paraphilic disorders in parkinson’s disease: a systematic review of the literature. Mov Disord. 2015;30:604–13.CrossRefGoogle Scholar
  57. 57.
    Lee JKP, Jackson H, Pattison P. Developmental risk factors for sexual offending. Child Abuse Negl. 2002;26(1):73–92.CrossRefPubMedGoogle Scholar
  58. 58.
    Barbaree HE, Langton CM, Blanchard R, et al. Predicting recidivism in sex offenders using SUR-20: the contribution of age at release. Int J Forensic Ment Health. 2008;7:47–64.CrossRefGoogle Scholar
  59. 59.
    Thibaut F, De La Barra F, Gordon H, et al. The world federation of societies of biological psychiatry guidelines for the biological treatment of paraphilias. World J Biol Psychiatry. 2010;11:604–55.CrossRefPubMedGoogle Scholar
  60. 60.
    Sorrentino RM. Paraphilias in Kaplan & Sadock’s comprehensive textbook of psychiatry. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009. p. 2090–8.Google Scholar
  61. 61.
    Beech AR, Harkins L. DSM-IV paraphilias: description, demographics and treatment intervention. Aggress Violent Behav. 2012;17:527–39.CrossRefGoogle Scholar
  62. 62.
    Morin JW, Levenson JS. Exhibitionism: assessment & treatment. In: Laws DL, O'Donohue WT, editors. Sexual deviance: theory, assessment, and treatment. 2nd ed.; 2008. p. 76–107.Google Scholar
  63. 63.
    Plaud JJ. Sexual disorders. In: Sturmey P. editors. Functional analysis of clinical treatment; 2007. p. 357–378.Google Scholar
  64. 64.
    Kraus C, Strohm K, Hill A, et al. Selective serotonin reuptake inhibitor in the treatment of paraphilia. Fortschr Neurol Psych. 2007;75(6):351–6.CrossRefGoogle Scholar
  65. 65.
    Emmanuel NP, Lydiard RB, Ballenger JC. Fluoxetine treatment of voyeurism. Am J Psychiatry. 1991;148(7):950.PubMedGoogle Scholar
  66. 66.
    Bourgeois JA, Klein M. Risperidone and fluoxetine in treatment of pedophilia with comorbid dysthymia. J Clin Psychopharmacol. 1996;16:257–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Case Western Reserve University School of Medicine, MetroHealth Medical CenterClevelandUSA
  2. 2.Primary Health CenterRampurIndia

Personalised recommendations